The World Health Organization declared on July 14 that 80% of new Ebola cases in eastern Congo are emerging from unknown chains of transmission, a sign that the outbreak is spreading faster than health workers can contain it. With nearly 2,000 confirmed infections and more than 700 deaths in two months, the Bundibugyo virus outbreak is now the third-largest Ebola epidemic on record and the fastest-growing ever documented on the African continent.
An Outbreak That Has Outrun Its Response
WHO Executive Director of Health Emergencies Chikwe Ihekweazu delivered the assessment from Geneva after returning from Bunia, the capital of Ituri Province in eastern Congo and the geographic center of the outbreak. Ihekweazu told reporters that single-day case counts have exceeded 80 confirmed infections, a rate of daily growth unprecedented across any of the 17 Ebola outbreaks Congo has experienced. As of July 13, the Congolese Ministry of Health reported 1,963 confirmed cases and 719 deaths across five provinces.
The 80% figure — the share of new cases that cannot be traced to any known contact — represents the outbreak’s most dangerous characteristic. In a functioning Ebola containment operation, health workers trace the contacts of every confirmed patient, monitor those individuals for 21 days, and isolate anyone who develops symptoms. When the majority of new infections appear outside those contact lists, it means transmission is happening in communities that the response has not reached, among people who may not know they have been exposed.
Ihekweazu compared the situation to a fire burning at its center while simultaneously expanding at its edges. WHO modeling suggests the true scale of the outbreak could be two to four times the official case count, with many deaths occurring in homes and communities where individuals never reached a health facility.
The Bundibugyo Strain Complicates Every Aspect Of The Response
The virus driving this outbreak is not the Zaire strain that caused the massive 2014–2016 West Africa epidemic or the more recent 2018–2020 outbreak in North Kivu. It is the Bundibugyo ebolavirus, a rarer species with only two previously documented outbreaks — one in Uganda in 2007–2008 and another in Congo’s Isiro region in 2012. That distinction matters because every approved Ebola treatment and vaccine currently in existence was developed specifically for the Zaire strain. The Bundibugyo virus has different surface proteins, which means therapeutics that proved effective against Zaire may not work against the current pathogen.
Clinical trials for Bundibugyo-specific treatments began in early July at the Evangelical Medical Center in Bunia, after the Coalition for Epidemic Preparedness Innovations fast-tracked three vaccine candidates in late May. WHO granted emergency use authorization for the first molecular diagnostic test capable of identifying the Bundibugyo strain, expanding lab capacity from a single facility at the outbreak’s start to 14 labs across the affected region. But none of these tools have yet produced a proven treatment that clinicians can administer at scale.
The absence of an approved therapeutic raises the stakes of early detection and supportive care. Patients who reach treatment centers and receive intravenous fluids, electrolyte management, and monitoring have meaningfully higher survival rates than those who remain in their communities. The overall case fatality rate across the outbreak stands at roughly 37%, but in North Kivu province, where armed conflict limits access to health infrastructure, the mortality rate has climbed to 57.4%.
Funding Gaps, Strikes, And Security Threats Undermine The Ground Response
The operational challenges facing health workers in eastern Congo extend well beyond the virus itself. Ituri and North Kivu provinces remain active conflict zones, with large areas of territory controlled by the M23 armed group and other militia factions. Healthcare workers have faced direct attacks on treatment centers — a pattern that echoes the violence that plagued the 2018–2020 Ebola response in the same region and contributed to that outbreak’s 26-month duration.
On July 14, dozens of healthcare workers at an Ebola treatment center in northeast Congo went on strike over unpaid salaries and bonuses. In a formal notice to the government, workers cited inadequate supplies, low pay, the “arrogance” of teams deployed from Kinshasa, and the preferential hiring of workers from other provinces over local Ituri residents. A strike at an active treatment center during the fastest-growing Ebola outbreak on record represents exactly the kind of compounding failure that allows transmission to accelerate.
Ihekweazu acknowledged the funding gap directly, noting that despite encouraging progress on diagnostic capacity and bed expansion — treatment capacity in Bunia has grown to approximately 800 beds — the response has not caught up to the virus. Treatment capacity is scaling, but the disease is scaling faster.
International Dimensions Of A Regional Crisis
The outbreak has already crossed borders. Uganda has reported 20 confirmed cases and two deaths, with all Ugandan infections linked to travel from Congo or subsequent local transmission events. A U.S. citizen working for a humanitarian organization in Congo tested positive on July 11 and was medically evacuated to Germany on July 13. France reported an imported case in late June; the patient recovered and was discharged from a hospital in early July. The European Centre for Disease Prevention and Control assessed the likelihood of infection for residents of the European Union as “very low” but continues to monitor the situation.
The United States implemented public health entry screening and travel restrictions for individuals arriving from affected provinces in Congo and Uganda on May 18. The U.S. Centers for Disease Control and Prevention issued an updated order on July 13 continuing the suspension of entry for certain foreign nationals from affected areas for an additional 30 days. The CDC recommends avoiding non-essential travel to Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo provinces.
What The Next Month Will Determine
The trajectory of this outbreak over the coming weeks will depend on whether the international community closes the gap between the response’s capacity and the virus’s pace of transmission. Ihekweazu framed the stakes in terms that extended beyond Congo’s borders, urging the world to act in its “own enlightened best interest” rather than treating the response as charity. WHO member states are simultaneously negotiating the Pathogen Access and Benefit Sharing annex of the WHO Pandemic Agreement, which would establish frameworks for sharing genetic information on dangerous pathogens and distributing vaccines to developing countries.
Whether those negotiations produce binding commitments or stall in procedural disputes will shape the global health infrastructure’s ability to respond to the next outbreak — and the one after that. For now, the fire Ihekweazu described in Ituri Province is still burning, still expanding, and still outrunning the teams trying to contain it.
